WASHINGTON (AP) — Food and drug regulators in the U.S., Europe and
other developed countries should offer training, technology and expertise to
developing nations in Asia, Latin America and other regions to better assure
the safety of imported products, states a new report.
An expert panel assembled by the Institute of Medicine recommends the
U.S. Food and Drug Administration work with counterparts throughout the world
to secure supply chains for imported food and drugs, which increasingly cross
borders. More than 80 percent of pharmaceutical ingredients are imported from
abroad, as well as 85 percent of the seafood consumed in the U.S., according to
federal figures.
"The integrated global economy demands cooperation across borders
— to thwart terrorists, reduce environmental hazards, and ensure that our food
and medical products are safe and effective," states the 300-page report
released Wednesday.
The report comes one day after the FDA announced a new investigation
into counterfeit vials of the popular cancer drug Avastin sold to U.S. doctors.
U.K. regulators said Wednesday the product was purchased from Turkey by
licensed U.K. distributors. The counterfeit Avastin is the second batch to make
its way into the U.S. in the last two months. The agency began investigating a
similar case in February that has been traced to the Middle East, though the
original country of origin is unclear.
Previous import safety scares have involved contaminated seafood, pet
food and blood thinning drugs from China.
The 12-member panel of experts recommends the U.S. and its
"technologically advanced counterparts" in Europe, Canada and Japan
share inspection duties for facilities in developing countries.
"There is no need for American and European inspectors to examine
the same facilities, especially when a vast number of facilities go
uninspected," the committee said.
The FDA has taken steps to boost inspections of foreign facilities in
recent years, while acknowledging it will be impossible to visit every source
of imported goods. The agency is responsible for imports from more than 300,000
foreign facilities in 150 different countries. A 2010 report by the Government
Accountability Office reported that FDA inspected fewer than 11 percent of the
plants on its own list of high-priority sites.
The Institute of Medicine is a nonpolitical group of experts that
advises the federal government on medical issues. Its recommendations often
make their way into laws drafted by Congress and policies implemented by
federal agencies. The new report was requested by the Food and Drug
Administration.
MATTHEW PERRONE
AP
Business & Investment Opportunities
YourVietnamExpert is a division of Saigon Business Corporation Pte Ltd, Incorporated in Singapore since 1994. As Your Business Companion, we propose a range of services in Strategy, Investment and Management, focusing Healthcare and Life Science with expertise in ASEAN. We also propose Higher Education, as a bridge between educational structures and industries, by supporting international programmes. Many thanks for visiting www.yourvietnamexpert.com and/or contacting us at contact@yourvietnamexpert.com
No comments:
Post a Comment